SAN ANTONIO -- (BUSINESS WIRE) -- iTraumaCare, an early-stage medical device firm focused on developing traumatic injury solutions for first responder and military medicine applications, has established its North American sales channel with the selection and training of the following civilian distributors for their first product, the iTClamp Hemorrhage Control System. Each distributor will cover a specific region of North America:
Specific contact information and more details on each distributor are available at iTraumaCare.com.
iTraumaCare’s CEO and founder, Dr. Dennis Filips, said, “We selected these distributors due to their extensive depth of experience and proven track record in working with first responders and acute care facilities across the United States.”
The iTClamp is designed to control severe bleeding – a leading cause of death in traumatic injury – in seconds. The iTClamp seals the edges of a wound closed to create a temporary pool of blood under pressure, which forms a stable clot that mitigates further blood loss until the wound can be surgically repaired. It is available in the US, European Union and Canada.
The iTClamp is the first product from iTraumaCare, an emerging medical device firm based in Edmonton, Canada with global commercialization headquarters in San Antonio, Texas. iTraumaCare is addressing unmet needs in the field of emergency medicine by developing, manufacturing, and commercializing solutions to treat common causes of preventable death in traumatic injury scenarios.